CD95 Signaling via Ceramide-rich Membrane Rafts*

Clustering seems to be employed by many receptors for transmembrane signaling. Here, we show that acid sphingomyelinase (ASM)-released ceramide is essential for clustering of CD95.In vitro and in vivo, extracellularly orientated ceramide, released upon CD95-triggered translocation of ASM to the plasma membrane outer surface, enabled clustering of CD95 in sphingolipid-rich membrane rafts and apoptosis induction. Whereas ASM deficiency, destruction of rafts, or neutralization of surface ceramide prevented CD95 clustering and apoptosis, natural ceramide only rescued ASM-deficient cells. The data suggest CD95-mediated clustering by ceramide is prerequisite for signaling and death.

[1]  G. Natoli,et al.  Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. , 1998, Biochemical pharmacology.

[2]  R. Dobrowsky,et al.  Association of p75 NTR with Caveolin and Localization of Neurotrophin-induced Sphingomyelin Hydrolysis to Caveolae* , 1997, The Journal of Biological Chemistry.

[3]  T. Mak,et al.  CD28 signals through acidic sphingomyelinase , 1995, The Journal of experimental medicine.

[4]  J. Dichgans,et al.  Fas/CD95/Apo-I activates the acidic sphingomyelinase via Caspases , 1998, Cell Death and Differentiation.

[5]  R. G. Anderson,et al.  Caveolae: where incoming and outgoing messengers meet. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Kinnunen,et al.  Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. , 1998, Biochemistry.

[7]  Richard G. W. Anderson,et al.  Compartmentalized Production of Ceramide at the Cell Surface (*) , 1995, The Journal of Biological Chemistry.

[8]  R. Parton,et al.  Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  J. Bouwstra,et al.  Phase behavior of stratum corneum lipids in mixed Langmuir-Blodgett monolayers. , 1996, Biophysical journal.

[10]  K. Kwiatkowska,et al.  The role of cholesterol and sphigomyelin in tyrosine phosphorylation of proteins and capping of Fcgamma receptor II. , 1999, Acta biochimica Polonica.

[11]  J. Camonis,et al.  Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (*) , 1995, The Journal of Biological Chemistry.

[12]  J. Ahn,et al.  TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. , 1999, Journal of immunology.

[13]  S. Mayor,et al.  Cell surface dynamics of GPI-anchored proteins. , 1997, Advances in experimental medicine and biology.

[14]  E. Westbrook,et al.  The three-dimensional crystal structure of cholera toxin. , 1995, Journal of molecular biology.

[15]  J. Tschopp,et al.  Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity , 1998, The Journal of experimental medicine.

[16]  T. Tedder,et al.  Syn‐capping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells , 1993, Journal of leukocyte biology.

[17]  D. Bar-Sagi,et al.  Co-capping of ras proteins with surface immunoglobulins in B lymphocytes , 1990, Nature.

[18]  M. Krönke,et al.  TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdown , 1992, Cell.

[19]  D. Mueller,et al.  Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation. , 1999, Journal of immunology.

[20]  R. Mitchell,et al.  A Role for Lipid Rafts in B Cell Antigen Receptor Signaling and Antigen Targeting , 1999, The Journal of experimental medicine.

[21]  Leslie,et al.  Phospholipases A2. , 1997, Seminars in cell & developmental biology.

[22]  F. Lang,et al.  L-selectin stimulates the neutral sphingomyelinase and induces release of ceramide. , 1998, Experimental cell research.

[23]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[24]  J. Hörber,et al.  Sphingolipid–Cholesterol Rafts Diffuse as Small Entities in the Plasma Membrane of Mammalian Cells , 2000, The Journal of cell biology.

[25]  F. Lang,et al.  CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. , 2000, Science.

[26]  M. Murakami,et al.  Functional Association of Type IIA Secretory Phospholipase A2 with the Glycosylphosphatidylinositol-anchored Heparan Sulfate Proteoglycan in the Cyclooxygenase-2-mediated Delayed Prostanoid-biosynthetic Pathway* , 1999, The Journal of Biological Chemistry.

[27]  S. Abraham,et al.  Involvement of cellular caveolae in bacterial entry into mast cells. , 2000, Science.

[28]  T. Meyer,et al.  Acidic Sphingomyelinase Mediates Entry of N. gonorrhoeae into Nonphagocytic Cells , 1997, Cell.

[29]  R. Zidovetzki,et al.  Ceramides modulate protein kinase C activity and perturb the structure of Phosphatidylcholine/Phosphatidylserine bilayers. , 1999, Biophysical journal.

[30]  J. Altman,et al.  Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. , 1998, Immunity.

[31]  Colin R. F. Monks,et al.  Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.

[32]  F. Goñi,et al.  Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. , 1999, Biophysical journal.

[33]  J. Alberola-Ila,et al.  Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. , 1999, Journal of immunology.

[34]  R. Testi,et al.  Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase , 1994, The Journal of experimental medicine.